XML 16 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash flows from operating activities:    
Net income $ 46,606 $ 9,674
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, amortization and accretion expense 61,523 56,732
Amortization of deferred financing costs 2,053 1,182
Credit loss expense 139 70
Deferred income tax benefit (677) (2,199)
Equity-based employee and director compensation expense 1,608 1,096
Loss (gain) on dispositions and lease terminations, net 620 (375)
Changes in operating assets and liabilities, net of acquisitions 14,588 10,087
Net cash provided by operating activities 126,460 76,267
Cash flows from investing activities:    
Principal payments received on notes receivable 102 151
Proceeds from sale of assets 4,398 11,012
Capital expenditures (26,784) (32,370)
Cash paid in connection with acquisitions, net of cash acquired (1,885) (261,993)
Net cash used in investing activities (24,169) (283,200)
Cash flows from financing activities:    
Borrowings under revolving credit facilities 64,600 167,000
Repayments on revolving credit facilities (101,815) (43,452)
Borrowings under the Term Loan Facility 1,120 159,950
Repayments on the Term Loan Facility (24,600)  
Net proceeds from issuance of preferred membership interests 24,430  
Payments of finance lease obligations (2,030) (1,944)
Payments of deferred financing costs (6) (7,135)
Distributions paid on distribution equivalent rights (137) (93)
Distributions paid on common units (59,713) (59,659)
Net cash (used in) provided by financing activities (98,151) 214,667
Net increase in cash and cash equivalents 4,140 7,734
Cash and cash equivalents at beginning of period 7,648 513
Cash and cash equivalents at end of period $ 11,788 $ 8,247